Background {#section1-2055102914565495}
==========

Increasing rates of breast cancer along with improvements in prognosis mean that the number of survivors is growing across all US populations, regardless of race, ethnicity, and socioeconomic status. As of January 2014, it was estimated that there were 14.5 million cancer survivors, representing approximately 4 percent of the population, with female breast as the most common cancer site representing 41 percent of female survivors ([@bibr91-2055102914565495]). Weight gain is a common and persistent problem for many breast cancer survivors (BCSs) ([@bibr68-2055102914565495]). A review of 23 studies that assessed weight gain in BCSs (17 of which reported on women previously diagnosed at stages I--III) found that 50--96 percent of women with breast cancer experience significant weight gain during treatment and many, including some women who remain weight stable during treatment, report progressive weight gain in the months and years after diagnosis ([@bibr121-2055102914565495]). Among those who gain weight, average increases range from 2.5 to 6.2 kg ([@bibr38-2055102914565495]; [@bibr52-2055102914565495]; [@bibr90-2055102914565495]). In one of the largest cohorts studied, with over 3000 BCSs participating in the Women's Healthy Eating and Living (WHEL) study, weight gain was found to be positively associated with chemotherapy of any type, but less likely among the oldest and the most obese at diagnosis (body mass index (BMI) ≥ 35 kg/m^2^). Even in this very large study, however, only 10 percent returned to pre-diagnosis weight, reinforcing that despite conditions that vary the risk, weight gain is highly prevalent among stage I--III BCSs ([@bibr107-2055102914565495]). The bulk of the studies do not report on weight gain for women diagnosed with metastatic cancer, nor address concerns about weight management ([@bibr107-2055102914565495]; [@bibr121-2055102914565495]). Further references to BCSs in this review regarding patterns associated with weight gain and suggestions for interventions to address the need of weight management, then, primarily address women in the nonmetastatic stages, working toward recovery and prevention of recurrence, past primary treatment.

Overweight and obesity at diagnosis, later weight gain, and sedentary behavior add to the risk of recurrence and all-cause mortality for BCSs ([@bibr14-2055102914565495]; [@bibr23-2055102914565495]; [@bibr26-2055102914565495]; [@bibr44-2055102914565495]; [@bibr92-2055102914565495]; [@bibr99-2055102914565495]), making physical activity (PA) and weight loss for overweight and obese BCSs important targets of behavioral interventions.

Currently, there is a burgeoning interest in meditative movement (MM) practices among BCSs, including Tai Chi (TC), Yoga, and Qigong (QG). Evidence is accruing that MM may nudge the scales in a favorable direction, reducing weight and/or BMI in a number of populations without the typical, perceived hard work of vigorous PA and radical intentional reductions in dietary energy intake. For example, a number of studies have shown reductions in BMI or weight loss in diabetic populations in response to TC ([@bibr20-2055102914565495]) or QG ([@bibr78-2055102914565495]), and women with binge eating disorders, post-menopausal women, and adults with metabolic syndrome have reduced BMI in response to Yoga ([@bibr73-2055102914565495]; [@bibr79-2055102914565495]; [@bibr82-2055102914565495]). There is some indication that this pattern may also hold for BCSs, a population particularly at risk for consequences of overweight and obesity ([@bibr61-2055102914565495]; [@bibr72-2055102914565495]). It is possible that, with the added impetus for recovering from fatigue and the hope for avoiding recurrence, BCSs might be a population particularly ready to adopt new behaviors and be more successful at changing and maintaining a new health routine.

Our purpose in this article is to first summarize a set of biobehavioral factors that interact, explaining how weight gain occurs so frequently in BCSs, and then propose mechanisms for how this specific category of practices, MM, may provide an opportunity for discovering a novel path to weight loss.

Breast cancer and weight gain {#section2-2055102914565495}
=============================

The cascade of events during the diagnosis and treatment phases for women with breast cancer leads to weight gain for most, and then the problem persists into the post-treatment survivorship phase. Explanations for weight gain related to diet and PA levels are particularly relevant for this group of vulnerable women. Higher calorie consumption has been implicated as a possible reason for weight gain during breast cancer treatment ([@bibr38-2055102914565495]; [@bibr52-2055102914565495]; [@bibr102-2055102914565495]). PA levels decline after diagnosis, with greater decline among women treated with chemotherapy and radiation or those who are obese ([@bibr56-2055102914565495]). Changes in resting energy expenditure during breast cancer treatment ([@bibr51-2055102914565495]) additionally contribute to the energy imbalance by reducing the energy requirements for individuals and resulting in weight gain even among those who maintain the same level of consumption and activity. Chemotherapy, especially those containing docetaxel and hormonal therapies, appears to exacerbate the problem (even more so for pre-menopausal women) ([@bibr37-2055102914565495]; [@bibr121-2055102914565495]).

Beyond the critical energy balance relationships, there is an emerging picture of neuroendocrine factors associated with stressful life events that appear to not only spur weight gain for those who are highly stress reactive (i.e. respond to stress with sudden increases in cortisol that may, in turn, trigger eating) ([@bibr43-2055102914565495]) but also contribute to weight maintenance after treatment ends. Although the relationships are complex and not fully understood, we focus here on a few of the established relationships, focusing on factors that have either been demonstrated as part of the profile of BCSs or for sedentary, stressed, overweight individuals---and in many cases, these profiles are similar. What follows is a description of how a number of psychological and behavioral factors interact with neuroendocrine markers related to BCSs and weight in stressful conditions (particularly the diagnosis and treatment for breast cancer), generally showing how "feeling physically poor" and "feeling emotionally poor" work together to make healthy behaviors and positive psychological states even less likely, thus sustaining the cycle.

Women with breast cancer experience significant stress during diagnosis and treatment of breast cancer ([@bibr4-2055102914565495]; [@bibr110-2055102914565495]), even after treatment completion ([@bibr110-2055102914565495]). In particular, continuous psychological stress and emotional distress such as anxiety, depression, and fear are shown to be prevalent in BCSs ([@bibr50-2055102914565495]), conditions that have a substantial negative influence on biological, physiological, and behavioral factors. Prolonged or frequent stress over diagnosis and treatment of cancer gives rise to disruption of the hypothalamic--pituitary--adrenal (HPA) axis ([@bibr41-2055102914565495]; [@bibr119-2055102914565495]) resulting in metabolic disruption ([@bibr3-2055102914565495]; [@bibr120-2055102914565495]) including increased insulin resistance and its concomitant metabolic abnormalities ([@bibr39-2055102914565495]). These patterns indicative of metabolic syndrome, along with sedentariness, are common in BCSs ([@bibr58-2055102914565495]).

Chronic stress is further associated with changes in cortisol patterns. Higher levels of cortisol and flatter diurnal rhythms have been observed in women with breast cancer ([@bibr1-2055102914565495]; [@bibr109-2055102914565495]), and early stage survivors with fatigue show low waking levels of cortisol with flattened slopes ([@bibr11-2055102914565495]). The increased sensitization of the HPA axis by psychological stress and associated cortisol disruption contributes to physiological and behavioral declines such as poor sleep and fatigue (the most common symptom in cancer patients) ([@bibr7-2055102914565495]; [@bibr11-2055102914565495]). The rise in cortisol secondary to chronic stress has been strongly associated with weight gain ([@bibr123-2055102914565495]).

Emotional distress prevalent among BCSs ([@bibr50-2055102914565495]; [@bibr124-2055102914565495]) may also be linked to emotional eating, a key factor associated with weight gain. Somatic dissociation (i.e. a stepping back from body awareness, often associated with extreme stress) accompanying the experience of breast cancer ([@bibr69-2055102914565495]) may persist into the survivorship phase ([@bibr28-2055102914565495]). A tendency to remove oneself from somatic experiences and reduction in body awareness may be related to various forms of disordered eating, including binge and emotional eating patterns ([@bibr65-2055102914565495]).

The high prevalence of fatigue among BCSs may diminish activities over daily life or lead to increasingly sedentary behaviors. These declined activities or sedentary behaviors may cause isolation and depression, resulting in further decrease in activity ([@bibr45-2055102914565495]). This fatigue cycle can further influence emotional eating and weight gain ([@bibr35-2055102914565495]; [@bibr48-2055102914565495]).

HPA axis disruption also contributes to immune and inflammatory factor dysregulation. Women with breast cancer and BCSs have shown significantly high C-reactive protein (CRP) and interleukin (IL)-6 ([@bibr2-2055102914565495]; [@bibr9-2055102914565495], [@bibr10-2055102914565495], [@bibr12-2055102914565495]; [@bibr55-2055102914565495]; [@bibr106-2055102914565495]).CRP, an indicator of systemic inflammation, is known to be elevated in people who are overweight, and in a high proportion of BCSs ([@bibr2-2055102914565495]), both pre- and post-menopausal [@bibr13-2055102914565495]. It has been shown that CRP binds to plasma leptin (the hunger-suppressing hormone associated with overweight) and impairs leptin signaling, suggesting CRP is not only a marker for inflammation-related co-morbidities, but may be involved in regulation of adiposity through leptin resistance and hunger cues ([@bibr19-2055102914565495]). Therefore, CRP linked to the stress response ([@bibr96-2055102914565495]; [@bibr114-2055102914565495]; [@bibr125-2055102914565495]) may hold a clue to the continued weight gain of BCSs and would be important to explore.

Many breast cancer patients and survivors, even years after completing treatment, continue to experience sleep dysfunctions ([@bibr122-2055102914565495]) that trigger inflammation theorized to mediate emotional distress (e.g. anxiety, depression) ([@bibr59-2055102914565495]) and fatigue. These persistent symptoms are all associated with overweight ([@bibr97-2055102914565495]) and are potentially related to continued elevation of cortisol and CRP with depressed leptin into the evening hours (when cortisol should be decreasing to allow sleep, and leptin should be increasing to curb hunger prior to sleep) ([@bibr113-2055102914565495]). Lower sleep duration is correlated with weight and weight gain (with progressively higher weight gain with each hour less sleep than 7 hours per night), perpetuating the problem through the cycle of biochemical imbalances that arise as sleep worsens. This "perfect storm" seems to be a cycle that is difficult to break ([@bibr98-2055102914565495]).

Given the number of emotional, psychological, and behavioral factors and neuroendocrine disruptions for some BCSs contributing to gaining and maintaining overweight, it appears that a multi-factor approach to turn this tide is needed. In the next section, we discuss traditional approaches and then consider an approach to weight management for BCSs that addresses the stress response as a first step and that initiates a mind--body type of PA to begin shifting emotional distress, sleep patterns, and neurohormonal balance.

Weight loss for BCSs {#section3-2055102914565495}
====================

PA and energy balance {#section4-2055102914565495}
---------------------

Most weight loss interventions for the general population aim to alter energy balance by increasing energy expenditure through increasing the level of PA or reducing energy intake, or both. Weight loss programs in general depend heavily upon nutrition education, external control, and behavior change models and are difficult to sustain with or without PA ([@bibr54-2055102914565495]; [@bibr104-2055102914565495]; [@bibr116-2055102914565495]). Randomized trials assessing the effectiveness of popular diets among healthy individuals report modest weight loss only among a minority of individuals who are able to maintain a high level of adherence to these restrictive diets ([@bibr29-2055102914565495]). Furthermore, there is generally poor sustainability in adherence to diets over time among study participants. While the overall patterns of activity intensity and activity-duration-to-inactivity ratios are considered critical, it has also been shown that *participation in regular PA* is associated with weight maintenance ([@bibr100-2055102914565495]).

Dietary counseling interventions produce modest weight losses that diminish over time in general populations ([@bibr30-2055102914565495]) as well as cancer survivors ([@bibr89-2055102914565495]). Weight loss interventions among BCSs have been less studied, but again, generally follow the model of increasing PA and/or lowering energy intake to reduce weight and improve body composition ([@bibr25-2055102914565495]; [@bibr36-2055102914565495]; [@bibr49-2055102914565495]; [@bibr80-2055102914565495]; [@bibr117-2055102914565495]) with benefits also shown for strength training ([@bibr108-2055102914565495]).

Exercise has been declared an important "medicine" for a number of symptoms and improving quality of life among cancer survivors ([@bibr108-2055102914565495]) while addressing weight gain; there are many good reasons for promoting these lifestyle behaviors among BCSs. While there is limited evidence that certain dietary patterns, particularly low fat intake, are associated with breast cancer recurrence ([@bibr101-2055102914565495]; [@bibr103-2055102914565495]), PA has been shown to reduce risk for recurrence among BCSs ([@bibr21-2055102914565495]; [@bibr53-2055102914565495]; [@bibr57-2055102914565495]; [@bibr99-2055102914565495]).

The recent American College of Sports Medicine (ACSM) guidelines ([@bibr108-2055102914565495]) recommend that cancer survivors follow PA guidelines for the general population ([@bibr100-2055102914565495]), with adaptations to fit the disease profile. Reduction in insulin resistance is common with PA initiation; insulin resistance has been associated with carcinogenesis through stimulation of insulin/insulin-like growth factor (IGF)-1 signaling pathways that promote cell proliferation and suppress apoptosis ([@bibr47-2055102914565495]). Furthermore, hormonal profiles predicting recurrence are more favorable among survivors with lower BMI and those who are physically active ([@bibr81-2055102914565495]), further making PA an important intervention target, both for overall weight management as well as for a number of symptoms. Specifically among BCSs, PA has been shown to have a number of positive effects on health and fitness in BCSs independent of weight loss, including improvements in upper and lower body strength, fatigue, depression, body image, and health-related quality of life ([@bibr40-2055102914565495]; [@bibr111-2055102914565495]). Only a limited number of trials have demonstrated significant BMI loss, albeit small, among cancer survivors, with successes only achieved with nearly a year of intensive PA and dietary interventions ([@bibr36-2055102914565495]; [@bibr40-2055102914565495]; [@bibr111-2055102914565495]). In a 10-month PA and dietary intervention study, patients gained weight back with no significant differences between control and study groups at the 2-year follow-up ([@bibr25-2055102914565495]). Exploratory work is needed to evaluate a novel approach to weight management among this high-risk population.

MM: a potential intervention for weight loss for BCSs {#section5-2055102914565495}
-----------------------------------------------------

MM is defined by [@bibr70-2055102914565495] as practices that combine movement or postures, with meditative states and a focus on the breath to achieve deep states of relaxation, including forms such as QG, TC, or Yoga. Women who have been diagnosed with breast cancer are increasingly exploring complementary and alternative options during and after treatment, including mind/body exercise practices such as MM (e.g. Yoga, TC, QG) ([@bibr8-2055102914565495]; [@bibr18-2055102914565495]; [@bibr46-2055102914565495]; [@bibr86-2055102914565495]). Although these practices are often less exertive than conventional aerobic exercise, there is a growing body of evidence that MM---mind/body practices that also utilize movement---may reduce a number of symptoms and improve quality of life for BCSs ([@bibr60-2055102914565495]; [@bibr61-2055102914565495]; [@bibr71-2055102914565495]; [@bibr74-2055102914565495]; [@bibr75-2055102914565495]; [@bibr88-2055102914565495]; [@bibr93-2055102914565495], [@bibr94-2055102914565495]; [@bibr112-2055102914565495]). These changes in symptom reduction and quality of life in response to MM practices are, in and of themselves, important outcomes that have been addressed in the current literature for each of these practices, Yoga, TC, and QG. We turn our attention now to the potential for MM to affect a critical factor associated with breast cancer recurrence, weight loss.

Although, to date, there are only two studies that indicate that MM affects weight loss among BCSs ([@bibr72-2055102914565495]; [@bibr61-2055102914565495]), there are a number of dynamics inherent in MM practices that address the very factors that may be related to weight loss. Thus, although it might not appear that lower levels of exertion associated with many of the MM practices would predict a change in weight, consideration of these factors beyond the PA intensity suggests other influences may be operating.

A number of recent studies indicate that weight, or more specifically BMI, may be reduced in response to MM practices ([@bibr15-2055102914565495]; [@bibr77-2055102914565495]; [@bibr83-2055102914565495]), particularly for those who are overweight or obese ([@bibr20-2055102914565495]), even when compared to non-MM exercise controls ([@bibr20-2055102914565495]; [@bibr22-2055102914565495]; [@bibr33-2055102914565495]).

Findings from a recent pilot study ([@bibr72-2055102914565495]) indicate that with a low-intensity QG/TC intervention, BMI can be significantly reduced compared to a similar, low-intensity exercise that excludes the meditative and breath focus aspects of the QG/TC intervention *and* this low-intensity exercise may serve as a bridge to more moderate-intensity activities. Furthermore, a trend in the direction of decreased BMI was shown for BCSs in a recently published pilot study of TC compared to a sedentary psychosocial support control, also showing a significant difference in insulin levels (stable levels in TC) ([@bibr61-2055102914565495]). Why might this be? We propose a model that suggests how MM components (PA, meditative states, and breath focus) may affect a number of factors that shift the burden of stress ([Figure 1](#fig1-2055102914565495){ref-type="fig"}) and propose how MM may provide a multi-factor program for weight loss among overweight/sedentary BCSs with a previous diagnosis of up-to-stage-III breast cancer. For purposes of the presentation of this model and the relationships proposed, the factors discussed in the text are intended to be applied to BCSs. Although the formal definition of a survivor includes those from the time of diagnosis, we use the term, survivor in this case, to refer to those who have completed primary treatment (i.e. surgery, radiation, chemotherapies) and the literature supporting the proposed relationships is primarily focused on the post-treatment survivorship phase.

![Proposed model of effects of meditative movement on weight.](10.1177_2055102914565495-fig1){#fig1-2055102914565495}

PA component of MM {#section6-2055102914565495}
------------------

QG and TC have been reported to be low to moderate level of intensity ([@bibr84-2055102914565495]; [@bibr115-2055102914565495]) while Yoga practices may vary even more greatly up to high intensity ([@bibr105-2055102914565495]), and thus, there is a wide variety in the level of intensity in the MM practices showing up in intervention research. MM exercises have been associated with an increase in adherence to PA programs ([@bibr34-2055102914565495]), and overall patterns of increased activity in daily life, even beyond the MM practice ([@bibr70-2055102914565495]). While PA alone is considered to be a necessary lifestyle intervention to promote weight loss, MM may bring additional elements to bear on the constellation of critical factors. We suggest that increases in overall PA resulting from participation in MM may contribute to weight loss based on the PA increases alone. Even with varying levels of intensity, reduced sedentary behavior and increased overall PA over time have been linked to reduced stress, improvements in CRP levels ([@bibr64-2055102914565495]), improved cortisol patterns, blood glucose and sleep regulation ([@bibr24-2055102914565495]), reduced insulin resistance ([@bibr87-2055102914565495]), and lowered BMI with reduced fat/lean ratios.

Meditative states, breathing practice, mood, and weight {#section7-2055102914565495}
-------------------------------------------------------

A key component of MM is the mindful or meditative state and the relaxation response associated with slow, deep breathing. A growing body of research suggests that mindfulness-based interventions may reduce stress-related emotions (anxiety, depression) ([@bibr16-2055102914565495]; [@bibr95-2055102914565495]; [@bibr110-2055102914565495]; [@bibr124-2055102914565495]), metabolic imbalance ([@bibr32-2055102914565495]), and disordered eating ([@bibr65-2055102914565495]) through an emphasis on *body awareness, emotional self-regulation*, and *attention to inner "wisdom" cues*, as well as decreased BMI ([@bibr66-2055102914565495]; [@bibr67-2055102914565495]; [@bibr76-2055102914565495]). Mindfulness practices may also help maintain weight loss post-surgery in bariatric patients ([@bibr42-2055102914565495]), possibly facilitated by reductions in emotional eating and caloric intake.

While breathing practices alone have not been directly tested/associated with weight loss, the calming of emotional states and self-regulation associated with MM breathing practices ([@bibr5-2055102914565495]; [@bibr62-2055102914565495]; [@bibr85-2055102914565495]) implies potential for changing *emotional eating patterns and dietary intake*. Both Yoga and TC have been shown to improve metabolic state and psychological symptoms ([@bibr27-2055102914565495]; [@bibr77-2055102914565495]; [@bibr105-2055102914565495]; [@bibr118-2055102914565495]). Furthermore, there is evidence that mindfulness practice may reduce waking cortisol levels along with weight loss among obese women ([@bibr31-2055102914565495]).

[@bibr118-2055102914565495] propose a model of cascading effects for QG and TC for patients with depression shedding light on several routes through which weight loss may occur, including changes in symptoms (fatigue and sleep) and in serotonin levels, *cortisol*, and slowed release of glucocorticoids. Although very little has been done to test methods of normalizing cortisol in cancer patients, interventions that reduce stress have been relatively successful. Cortisol levels were reduced in acute response to Yoga practice ([@bibr63-2055102914565495]), and normal slopes were restored in a group of breast and prostate cancer patients who practiced mindfulness meditation ([@bibr17-2055102914565495]).

In summary, we propose that MM elements (meditative state, movement, breath focus) may increase emotional self-regulation and body awareness, eating behaviors, and PA in favor of weight loss. Diurnal cortisol slope improvements, reduced insulin resistance, and decreased CRP levels (reducing leptin resistance) may be centrally involved in the MM/weight loss relationship as mechanisms of change.

Discussion {#section8-2055102914565495}
==========

Although at first consideration, MM practices may not be seen as adequate exertion to change the metabolic processes expected to change for weight loss results, we suggest that there are other effects of various components of MM that may make a difference through other routes. Overall increase in activity levels as women become less sedentary is a typical result of MM practice. Furthermore, the stress effects on the HPA axis induced by breast cancer diagnosis and treatment may potentially be reversed through normalizing metabolic patterns, and inflammatory and immune biomarkers. At the same time, these markers of biochemical change may also reflect behavioral changes in sleep and emotional eating, turning the tide of the many factors noted to be related to the weight gain in the first place. With the growing evidence for MM practices to be effective for weight loss, and the factors theorized to be associated with these results, there is a need to examine more specifically these practices, and potential mechanisms of change for BCSs, in research designs addressing the full model.

The model of behavioral/physiological, psychological, and biological responses to MM expected to support weight loss among overweight BCSs includes a number of testable relationships. In the conceptual model (see [Figure 1](#fig1-2055102914565495){ref-type="fig"}), we propose several possible pathways by which MM interventions may impact weight loss. One pathway depicted suggests that the MM intervention leads to improved physiological (behavioral) responses (e.g. improved sleep quality), which then lead to weight loss. Evidence for MM intervention effects on sleep and the relationship of sleep and weight have been established, but the throughput of these relational factors has not been directly tested. This portion of the model could be tested using multiple regression analyses or path analyses to examine the role of physiological responses as mediators of the effect of MM on weight loss. Mediation models could also be used to examine the impact of MM interventions on psychological responses (e.g. emotional self-regulation), which then lead to weight loss, another pathway depicted in the conceptual model. Additionally, multiple mediator models could be used to examine the effect of an MM intervention on physiological and psychological responses simultaneously and whether one of these responses has an impact on weight loss while controlling for the effect of the other. Relevant research questions include "does MM have a stronger impact on physiological or psychological responses?" and "are physiological or psychological responses the stronger mediator of MM's impact on weight loss?" Finally, three path mediation models could be used to test the effects of the MM intervention on physiological/psychological responses which then lead to biological responses (e.g. diurnal cortisol slope improvement) and ultimately weight loss.

Finally, we recognize that one of the most powerful benefits that could accrue to finding MM effects on weight loss is the potential for preventing recurrence. As with any model that is in the early stages of being tested, the various components related to weight loss need to be tested first to better understand the relationships. If findings confirm this model, the next step would be to design studies for the longer term to examine effects on recurrence mediated by MM forms of activity.

Conclusion {#section9-2055102914565495}
==========

A model is proposed describing MM as an intervention venue for overweight BCSs that may provide an advantage over the typically prescribed diet and exercise solutions for some individuals, and asserting that this is a ripe area for testing in rigorous research. MM interventions may not only directly and indirectly address the usual culprits in weight gain (e.g. sedentariness and dietary intake) but also may begin to shift a number of underlying psychological and bio-mechanisms related to stress, potentially having more systematic and longer term effects.

**Funding:** This research was partially funded by the National Institutes of Health, National Center for Complementary and Alternative Medicine, 1U01AT002706-01A2, PI, Larkey.
